Navigation Links
Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting
Date:10/16/2009

e polyarticular juvenile idiopathic arthritis in children ages 2 and older.
  • ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with psoriatic arthritis. ENBREL can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone.
  • ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis.
  • ENBREL is indicated for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
  • IMPORTANT SAFETY INFORMATION

    What is the most important information I should know about ENBREL?

    ENBREL is a medicine that affects your immune system. ENBREL can lower the ability of your immune system to fight infections. Serious infections have happened in patients taking ENBREL. These infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some patients have died from these infections. Your doctor should test you for TB before you take ENBREL and monitor you closely for TB while on ENBREL.

    Before starting ENBREL, tell your doctor if you:

    • Think you have, are being treated for, have signs of, or are prone to infection. You should not start taking ENBREL if you have any kind of infection.
    • Have any open cuts or sores
    • Have diabetes or an immune system problem
    • Have TB or have been in close contact with someone who has had TB
    • Were born in, lived in, or traveled to countries where there is more risk for getting TB. Ask your doctor if you are not sure.
    • Live or have lived in certain parts of the country (such as, the Ohio and Mississippi River valleys, or the Southwest) where there is a greater risk for certain
      '/>"/>

    SOURCE Amgen
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine news :

    1. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
    2. Plastic Surgery 2009 News Briefs - Selected Research to be Presented on Tuesday, October 27
    3. Plastic Surgery 2009 News Briefs - Selected Research to be Presented on Monday, October 26
    4. Plastic Surgery 2009 News Briefs - Select Research to be Presented on Sunday, October 25
    5. Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24
    6. Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics (TCT) 2009
    7. PolyOne Presented with Frost & Sullivan Medical Product Award
    8. CRF announces featured clinical trials to be presented at TCT 2009 in San Francisco
    9. Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting
    10. Centers of Excellence Awards Presented to Over 100 Nursing Facilities as Nursing Facilities Reach the Tipping Point in Treating Pressure Ulcers
    11. CRF announces late breaking trials to be presented at TCT 2009 in San Francisco

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/23/2009)....Schwade,M.D.announcesthenewlyenhancedCyberKnifeeq...nterofMiami,( www.cyberknifemiami.com ). ,, T...intensedoseofradiationthatkillscancercellswithnoin...astfrom30minutestoonehour,andisusuallycompletedin1...enterintheSoutheasternU.S.,theMiamifacilityhasledt...
    (Date:11/23/2009)... mental and physical health , , MONDAY, ...take as many years off your life as smoking does, ...of depression and anxiety appears to be better for...came to their conclusions after analyzing death re...ing the four years after the survey, the death rat...
    (Date:11/23/2009)...the November issue of GIE: Gastrointestinal Endos...l of the American Society for Gastrointestinal End...found that Barrett,s esophagus was detected in six...ic screening. Also in this issue, two studies exam... France, in the largest single-center experience t...
    (Date:11/23/2009)...lth System study has found that one out of five Ty...100 pounds or more overweight. , Researchers rep... diabetes are obese, and 20.7 percent are morbidly...diabetes, 1 in 3 is morbidly obese. , "The rate ...creasing at a very alarming rate, and this has sub...
    (Date:11/23/2009)...rtment of Agriculture (USDA) has awarded a two-yea...ity of Minnesota to complete sequencing the genome...The funding will be used by the Turkey Genome Sequ...g using next-generation sequencing platforms, asse...unctions in the final genome sequence by use of a ...
    Breaking Medicine News(10 mins):Health News:Depression May Up Death Risk to That of Smoking 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5Health News:Diabetics show alarming increase in morbid obesity 2Health News:Turkey Genome Sequencing Consortium awarded $0.9 million from USDA 2
    ...on to,Protect Florida,s Drivers praised Governor C...him for expanding the call of this week,s special,...lt expired at midnight,today. Saying that Persona...vers and their passengers, Governor,Crist encourag...
    ...nnounced,that it has successfully emerged from cha...onths after filing for bankruptcy protection on Ju...by Harbinger Capital Partners,Master Fund I, Ltd. ...exchange for 100% of,the common equity of reorgani...
    ..., 2007, WASHINGTON, Oct. 1 The following is bein...benow, D-Michigan Rep. Emmanuel Cleaver, D-Missou...ev. Jim Wallis, Executive Director of Sojourners a... Social Justice Lobby Father Ray East - Executive...
    ...d public entities in the addiction treatment field...nges to Improve Outcomes Now (ACTION) Campaign for...The ACTION Campaign goals are to increase access t...eptember, has a goal of improving the lives of 55,...
    ...n,(Nasdaq: AIRM ), the largest air medical transp...t the Company has completed its acquisition of,100...gs, Inc. (parent,company of CJ Systems Aviation Gr... and was primarily,financed through a new five-yea...
    ...if given with 24 hours, study finds , , ...sed to treat severe acne and urinary tract infecti...te ischemic stroke, a new report from Israeli rese...rts say. , Though it is too early to change patien...
    Other Medicine News:Health News:Coalition to Protect Florida's Drivers Applauds Governor Crist for Adding PIP to Special Session 2Health News:Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds 2Health News:Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds 3Health News:Leaders in addiction treatment announce national 'ACTION' campaign 2Health News:Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc. 2Health News:Antibiotic Shows Promise as Stroke Treatment 2Health News:Antibiotic Shows Promise as Stroke Treatment 3
    (Date:11/23/2009)...re-FirstCall/--NeurobiologicalTechnologies,Inc.(Na...ectorshasdeclaredanextraordinarydividendof$0.18per...tostockholdersofrecordasofNovember30,2009.TheDecem...provalofthedissolutionofNTIpursuanttoaplanofcomple...rydividendof$0.75persharethatwaspaidtoshareholders...
    (Date:11/23/2009)...-AdvancedSterilizationProducts(ASP),aleadingglobal...theacquisitionbyitsFrenchaffiliate,ApsisS.A.S.,ofG...sinfectionprocessesandtechnologiestopreventhealthc...tdisclosed. ,, GlosterEuropedesignsandmarketsan...sdisinfectionofpatientenvironmentssuchashospitalan...
    (Date:11/20/2009)...e-FirstCall/ -- Escalon Medical Corp. (Nasdaq Mark...st quarter ended September 30, 2009. ,, For t...ecreased approximately $234,000, or 2.7%, to $8,43...r 30, 2009 as compared to the same period last fis...revenue of $8,434,000 compared with $8,669,000 in ...
    Breaking Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7LASIK Surgery Specialist G Brock Magruder Jr M D of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 14222 1LASIK Surgery Specialist G Brock Magruder Jr M D of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 14222 2LASIK Surgery Specialist G Brock Magruder Jr M D of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 14222 3LASIK Surgery Specialist G Brock Magruder Jr M D of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 14222 4LASIK Surgery Specialist G Brock Magruder Jr M D of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 14222 5LASIK Surgery Specialist G Brock Magruder Jr M D of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 14222 6LASIK Surgery Specialist G Brock Magruder Jr M D of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 14222 7Mountain Home Helps Companies Battle Tough Economic Times by Offering Free Lean Six Sigma Training 58111 1Mountain Home Helps Companies Battle Tough Economic Times by Offering Free Lean Six Sigma Training 58111 2Kayentis the Leading Provider of the Unique 26quot 3BPaper Based e Trial 26quot 3B Solution has been Retained for Six New Clinical Studies in the U 58106 1Kayentis the Leading Provider of the Unique 26quot 3BPaper Based e Trial 26quot 3B Solution has been Retained for Six New Clinical Studies in the U 58106 2
    ...July 21 Professor Terje Pedersen (Ulleval,Univers... the Simvastatin,and Ezetimibe in Aortic Stenosis ...on Monday the 21st July., Also present in London ...tistics and Epidemiology and Co-director of the Cl...Professor Rory Collins (BHF Professor of,Medicine ...
    ... Published in August Issue of Journal of Nutrition...f tea a,day may help maintain a healthy mind and b...lement to the August issue of the Journal of Nutri...e cups of tea a day may improve,attention and focu...uding,research on neurological health, genetic sus...
    Other Medicine Technology:New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer 2New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer 3New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer 4New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer 5
    ...ies everywhere, Model K Centrifuge have been provi...ecades in industrial testing facilities and labora...uality construction continue to make it a standard...., Designed for around-the-clock dependability, t...
    Avanti J-25
    ...en/Shaker rigidly controls the temperature and sha...f hybridization and washing steps. This facilitate...ids and proteins immobilized on Hybond membranes. ...ive labeling systems supplied by Amersham Bioscien...
    ...en/Shaker rigidly controls the temperature and sha...f hybridization and washing steps. This facilitate...ids and proteins immobilized on Hybond membranes. ...ive labeling systems supplied by Amersham Bioscien...
    Medicine Products: